Indicators

Markets:

News

Latest News about ALNY

Recent news which mentions ALNY

...

4 5 6 7 8 9 10 11 Next >

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

June 27, 2022

Seven reasons the beleaguered biotech sector is now a ‘buy’

June 17, 2022

The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate

June 14, 2022

Alnylam's Stock Gains Following FDA Nod For hATTR Amyloidosis Candidate

June 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022

June 07, 2022

Analyst Ratings for Alnylam Pharmaceuticals

June 07, 2022

Alnylam's Lumasiran Shows Clinical Benefit In Rare Kidney Disease

May 24, 2022

Why HC Wainwright Is Bullish On This Stock's Hepatitis-B Pipeline

May 02, 2022

10 Biggest Price Target Changes For Monday

May 02, 2022

Expert Ratings for Alnylam Pharmaceuticals

April 29, 2022

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

April 28, 2022

What To Know About Morgan Stanley's Downgrade of Alnylam Pharmaceuticals

April 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

April 25, 2022

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

April 24, 2022

7 Potential Biotech Stocks Buyout Targets in 2022

April 21, 2022

Alnylam Pharmaceuticals Q1 2022 Earnings Conference Call On April 28, 2022 At 08:30 AM ET

April 19, 2022

Analyst Ratings for Alnylam Pharmaceuticals

April 12, 2022

7 Biotech Stocks to Buy With Key Catalysts for April

April 05, 2022

See Why Did FDA Extend Review Period For Alnylam's Vutrisiran In Amyloidosis

April 04, 2022

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

April 01, 2022

3 Healthcare Stocks That Could Rise 28% or More, According to Wall Street

March 21, 2022

Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters

March 18, 2022

Alnylam Hits Pfizer, Moderna With Patent Infringement Suits

March 17, 2022

What 8 Analyst Ratings Have To Say About Alnylam Pharmaceuticals

March 01, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022

March 01, 2022

Looking Into Alnylam Pharmaceuticals's Return On Capital Employed

February 11, 2022

Expert Ratings For Alnylam Pharmaceuticals

February 11, 2022

Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B

February 10, 2022

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

February 10, 2022

Alnylam Pharmaceuticals: Q4 Earnings Insights

February 10, 2022

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.